0000899243-20-029501.txt : 20201028
0000899243-20-029501.hdr.sgml : 20201028
20201028161509
ACCESSION NUMBER: 0000899243-20-029501
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201027
FILED AS OF DATE: 20201028
DATE AS OF CHANGE: 20201028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dunne Michael W.
CENTRAL INDEX KEY: 0001553593
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38503
FILM NUMBER: 201268813
MAIL ADDRESS:
STREET 1: DURATA THERAPEUTICS, INC.
STREET 2: 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Iterum Therapeutics plc
CENTRAL INDEX KEY: 0001659323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE
STREET 2: HARCOURT STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (872) 225-6077
MAIL ADDRESS:
STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE
STREET 2: HARCOURT STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Iterum Therapeutics Ltd
DATE OF NAME CHANGE: 20151124
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-27
0
0001659323
Iterum Therapeutics plc
ITRM
0001553593
Dunne Michael W.
C/O ITERUM THERAPEUTICS PLC, BLK 2
FL. 3, HARCOURT CENTRE, HARCOURT ST.
DUBLIN
L2
2
IRELAND
0
1
0
0
Chief Scientific Officer
Ordinary Shares
2020-10-27
4
P
0
61540
A
209498
D
Warrants (right to buy)
0.65
2020-10-27
4
P
0
46155
A
2020-10-27
2025-10-27
Ordinary Shares
46155
46155
D
The reported securities were purchased in the Issuer's registered public offering on October 27, 2020 at a combined purchase price of $0.65 per ordinary share and warrant. Each ordinary share was purchased together with a warrant to purchase 0.75 of an ordinary share.
s/s Michael W. Dunne
2020-10-28